Holders · period archive

CRSP · Crispr Therapeutics AG

Q3 2024 13F holders among managers we track latest ownership dossier

Ticker: CRSP
Type: Equity
Class: NAMEN AKT
Total reported value ($000, long equity)

Manager	Report date	Value	Shares